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Luminol-enhanced luminescence is a method used to measure formation of reactive oxygen intermediates
important in the ability of neutrophils to kill microbes. Several studies have demonstrated that under some
conditions of incubation, ampicillin can inhibit neutrophil-derived luminol-enhanced luminescence. We
evaluated the mechanism(s) by which ampicillin inhibited the luminescent response of stimulated neutrophils.
We also investigated sulbactam, a 13-lactamase inhibitor which has been given in combination with ampicillin
and other beta-lactam antibiotics to increase their spectra, for possible similar effects. Both ampicillin and
sulbactam attenuated luminol-enhanced luminescence by approximately 40%. Superoxide production was not
prevented by added ampicillin, nor was superoxide scavenged by it. Myeloperoxidase reacts with H202 and Cl-
to generate OCl-, which is believed to be the oxidizer of luminol that is primarily responsible for enhancement
of neutrophil-derived luminescence. Hydroxyl radicals (HO'), which may also oxidize luminol, resulting in
luminescence, can be formed from 02 and H202 via either myeloperoxidase-dependent (involving interme-
diate OCI-) or myeloperoxidase-independent (through a metal ion catalyst) reactions. Ampicillin scavenged
H202 and OCl- and prevented 95% of Fenton reaction-generated HO' from reacting with 5,5-dimethyl-1-
pyrroline-N-oxide. Sulbactam was found to scavenge OCl- and HO0, but less avidly than ampicillin did.
Neither ampicillin nor sulbactam inhibited myeloperoxidase activity. Sublethal concentrations of sulbactam
had no significant effect on neutrophil killing of Staphylococcus aureus and Escherichia coli. Our results
demonstrate a mechanism(s) by which ampicillin inhibits luminol-enhanced luminescence from stimulated
neutrophils, namely, through scavenging of the oxidant(s) primarily responsible for the generation of
luminescence.
Polymorphonuclear neutrophils use both oxygen-depen-
dent and -independent mechanisms to kill microbial patho-
gens, including bacteria (12, 22). Some of the reactive
oxygen intermediates generated by neutrophils are as fol-
lows: polymorphonuclear neutrophil stimulation -- 02-
H202 + myeloperoxidase + Cl- OCI- (22) (reaction 1);
OCl- + 02- HO' (21) (reaction 2); and 02 + Fe3`
Fe2+ + H202 HO (10) (reaction 3). Luminol-enhanced
luminescence is an assay which has been used extensively to
measure the formation of reactive oxygen intermediates
generated by neutrophils during phagocytosis (1, 5, 9).
Hypochlorite (OCI-) (9) and hydroxyl radicals (HO') (13) are
among the reactive oxygen intermediates measured by lumi-
nol-enhanced luminescence.
Antibiotics can influence the outcome of the neutrophil
bactericidal process. Some antibiotics sensitize bacteria to
neutrophil killing (27) or facilitate neutrophil function (20,
25, 27). Ampicillin is the most widely used antibiotic in the
United States. However, it has been reported that ampicillin
inhibits neutrophil function in vitro, as measured by inhibi-
tion of luminol-enhanced luminescence (2, 23).
In this work, we examined the effects of ampicillin on the
reactions responsible for luminol-enhanced luminescence
(see reactions 1 through 3). In addition, we examined the
effects of sulbactam on these reactions. Sulbactam is a
1-lactamase inhibitor used in combination with ampicillin
and other beta-lactam antibiotics to enhance their spectra
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(17). It has previously been reported that sulbactam can
reverse neutrophil inhibition caused by ampicillin (23) and
facilitate bacterial killing (14, 20). Our results describe a
mechanism(s) by which ampicillin inhibits neutrophil func-
tion and offer further insight into the interactions among
ampicillin, sulbactam, and host defenses.
MATERIALS AND METHODS
Abbreviations used. The following abbreviations are used
in this paper: ROI, reactive oxygen intermediates; LEL,
luminol-enhanced luminescence; DMPO, 5,5-dimethyl-1-
pyrroline-N-oxide; MCD, 1,1-dimethyl-4-chloro-3,5-cyclo-
hexanedione (monochlorodimedon); KRG, Krebb's-Ring-
er's-glucose buffer; PMA, phorbol-12-myristate-13-acetate;
DTPA, diethylenetriaminepentaacetic acid; SOD, superox-
ide dismutase; PMN, polymorphonuclear neutrophils; EPR,
electron paramagnetic resonance; HBSS, Hanks balanced
salt solution.
Materials. Ampicillin was purchased from Wyeth Labora-
tories, Philadelphia, Pa. Sulbactam was obtained from Pfizer
Pharmaceuticals, Inc., New York, N.Y. MCD, sodium
hypochlorite, 5-amino-2,3-dihydro-1,4-pthalazinedione (lu-
minol), 4-aminoantipyrene, human myeloperoxidase, fer-
rous sulfate, DMPO, ferricytochrome c, DTPA, lumazine,
bovine liver catalase, SOD, taurine, PMA, and zymosan
were purchased from Sigma Chemical Co., St. Louis, Mo.
H202 (30%) was purchased from Fisher Scientific, Pitts-
burgh, Pa. DMPO was purified by vacuum distillation at
room temperature (25°C) and stored at -70°C under a
nitrogen atmosphere until use (4).
Preparation ofPMN. PMN were isolated from whole blood
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on the day they were used, as previously described (24),
using plasmagel to facilitate separation of the lymphocyte
layer from the erythrocytes and Ficoll-Hypaque density
centrifugation to separate PMN from monocytes. PMN
isolated in that manner were >95% viable as assayed by
trypan blue exclusion and were stored on ice in KRG until
used.
Preparation of opsonized zymosan. Zymosan suspended in
0.9% saline (5 mg/ml) was boiled for 15 min, washed three
times with 0.9% saline, and opsonized with 50% fresh
normal human serum from healthy adult donors for 30 min at
37°C in a bacterial culture shaker. Opsonized zymosan was
washed twice with 0.9% saline and was either used immedi-
ately (3-mg/ml final concentration in KRG) or stored for 1
day at a concentration of 5 mg/ml in 0.9% saline at -20°C.
Equivalent results were obtained whether the opsonized
zymosan was used immediately after preparation or after
storage overnight.
LEL. Reaction mixtures in 3.5-ml plastic tubes (Sarstedt
Inc., Newton, N.C.) each contained 0.6 ml of KRG initially
at 37°C, luminol (final concentration, 2.5 x 10-5 M), the
antibiotic to be tested, and PMN (final concentration, 2 x
105 cells per ml) and were adjusted to a total volume of 1 ml
with KRG. Reactions were initiated by the addition of
opsonized zymosan to a final concentration of 3 mg/ml. After
gentle mixing, the samples were placed in a Bio-Orbit 1250
luminometer at room temperature, and the luminescence
was recorded on a chart recorder.
Luminescence from added hypochlorite. Reaction mixtures
containing luminol (2.5 x 10-5 M final concentration) and
either ampicillin or sulbactam at the desired concentrations
were placed in the sample chamber of a Bio-Orbit 1250
luminometer at room temperature. Sodium hypochlorite (10
,ul from a stock prepared by diluting NaOCl 1:8,100 in KRG)
was injected into the reaction tube, and the luminescent
response was followed by use of a chart recorder.
Taurine chloramine preparation. Taurine chloramine was
prepared by adding hypochlorite (5 mM) to 15 mM taurine as
previously reported (26) and was used within 15 min of
preparation.
Superoxide generation by stimulated PMN. Freshly iso-
lated PMN (final concentration, 2 x 105 ml-1) were stimu-
lated with PMA (final concentration, 1 ,ug/ml) in a quartz
spectrophotometer cuvette containing ferricytochrome c (fi-
nal concentration, 20 ,uM), DTPA (final concentration, 0.1
mM), and catalase (7,500 U) (to prevent the reoxidation of
the ferrocytochrome c product by any H202 formed during
the reaction) with the addition of either ampicillin at 300
,ug/ml, sulbactam at 256 ,ug/ml, or SOD at 4.3 U/ml. The
reaction was initiated by addition of PMA, and 02 gener-
ation was monitored by the change in A550 as a function of
time, using a Varian DMS 80 spectrophotometer equipped
with a Fisher Recordall series 5000 chart recorder.
Superoxide scavenging by antibiotics. Superoxide scaveng-
ing was followed by a method identical to that used to follow
the rate of superoxide generation from neutrophils (see
above) except that instead of PMN and PMA, reaction
mixtures contained lumazine at a final concentration of 0.3
mM and reactions were initiated by the addition of xanthine
oxidase (4-mU/ml final concentration).
H202 decomposition. Reaction mixtures contained 14.5
mM H202, 0.1 mM DTPA, and either ampicillin (50 to 300
,ug/ml), sulbactam (256 ,ug/ml), both ampicillin (300 ,ug/ml)
and sulbactam (256 ,ug/ml), or buffer in a total reaction
volume of 3 ml in KRG. The concentration of H202 as a
function of time was monitored by the change in A240 in a
Varian DMS 80 spectrophotometer. Changes in H202 con-
centration were calculated by using an extinction coefficient
at 240 nm of 43 M1 cm-1 (6).
Catalase activity. Oxygen evolution from solutions of
H202, representing catalase activity, was monitored with a
YSI model 53 oxygen monitor equipped with a Clark-type
oxygen electrode recorded on a Fisher Recordall 5000 chart
recorder. The initial oxygen concentration was set to 20% 02
saturation with KRG as a standard prior to the addition of
H202 (19 mM)-
Myeloperoxidase activity. Activity of human myeloperox-
idase was quantified via the change in A510 of a solution of
4-aminoantipyrene in the presence of H202 as previously
described (19). Reaction mixtures contained 4-aminoan-
tipyrene (1.08 mM), phenol (8.8 mg/ml), H202 (0.88 mM),
and antibiotic or KRG in a total volume of 3.0 ml in KRG.
Measurement of OCI-. Hypochlorite concentrations were
measured by using the ability of OCl- to chlorinate MCD.
MCD (50 mM) was dissolved in 95% ethanol and was used at
a final concentration of 50 ,uM in KRG. Changes in MCD
concentration following the addition of 0.1 mmol of OCl-
were quantified via the change in A290, using a molar
extinction coefficient of 19,000 M-1 cm-1 for MCD (15).
NaOCl stock solution was prepared by diluting NaOCl 1:8.3
into KRG.
Hydroxyl radical detection. Hydroxyl radicals were gener-
ated via the reaction between Fe2+-EDTA and H202 and
observed after adduct formation with DMPO by EPR spec-
troscopy. For each experiment, H202 (final concentration, 1
to 10 mM) was added to a mixture of Fe2+-EDTA (0.2 mM),
DMPO (5 mM), and either ampicillin or sulbactam (5 mM) in
H20 (final volume, 1 ml). Mixtures were transferred to a
quartz flat cell, and EPR spectra were measured at room
temperature in a Varian E-102 EPR spectrometer equipped
with a TM110 cavity.
Bacterial killing assays. Escherichia coli ATCC 25922 or
Staphylococcus aureus 502A was grown to log phase (3 to 4
h) at 37°C with 5% CO2 in HBSS, and the bacteria were
collected by centrifugation, washed twice with HBSS, and
resuspended in HBSS at a concentration of 2.5 x 108 CFU
ml-,; 2.5 x 107 CFU was then incubated for 30 min at 37°C
and 5% CO2 with sulbactam concentrations of between 0 and
128 pg/ml. After the incubation, the cells were collected by
centrifugation, washed twice with HBSS, resuspended in
HBSS with 10% serum, and incubated for 0 to 2 h at 37°C
and 5% CO2. Surviving bacterial CFU were measured by
plating serial dilutions of incubation mixtures onto Luria
broth agar. The killing of bacteria by PMN was determined
by incubation of S x 107 CFU of E. coli or S. aureus with 5
x 106 PMN in HBSS supplemented with 10% serum at 37°C
and 5% C02, with aliquots being removed at 0, 20, 30, and 60
min, serially diluted, and plated onto Luria broth agar to
determine the number ofCFU surviving exposure to PMN at
each time point.
RESULTS
Chemiluminescence from PMN. Luminescence was quan-
tified either by the maximal slope of the luminescent re-
sponse (measured as millivolts minute-1) or by the lumines-
cence observed 8 min after the end of the latency period
between neutrophil stimulation and luminescent response.
Ampicillin, sulbactam, and the combination of both attenu-
ated the chemiluminescent response and lengthened the
latency period (Fig. 1). Inhibition of LEL was observed
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FIG. 1. Effect of ampicillin (300 ,ug/ml) and sulbactam (256 j±g/ml) on LEL from PMN (2 x 105/ml) stimulated with opsonized zymosan
(3 mg/ml). Control experiments are represented by open bars; ampicillin treatment of cells is represented by hatches rising to the right;
sulbactam treatment of cells is represented by hatches rising to the left; and combined ampicillin and sulbactam treatment is represented by
crosshatches. Results are the means and standard errors of the mean for experiments performed with four separate isolations of PMN, each
in duplicate or triplicate. The statistical significance of the results was analyzed with Student's t test. *, **, and *** indicate that the result
is significantly different from that of the control experiment (P < 0.1, P < 0.01, and P < 0.001, respectively).
(Fig. 2A) and when sulbactam was present at concentrations
above 64 ,ug/ml (Fig. 2B).
Ampicillin- and sulbactam-induced oxidant scavenging.
Scavenging of the oxidants produced by stimulated PMN
represents a potential mechanism for the attenuation of
chemiluminescence observed in the presence of ampicillin
and sulbactam. The oxidative burst of stimulated PMN
begins with reduction of 02 to superoxide. Neither ampicillin
at 300 ,ug/ml nor sulbactam at 256 ,ug/ml reduced the rate of
superoxide-induced ferricytochrome c reduction, whereas
SOD capably prevented the reduction of ferricytochrome c
under the same conditions (Table 1). Neither ampicillin nor
sulbactam prevented reduction of ferricytochrome c when
xanthine oxidase reacting with lumazine was used as an 02-
source (Table 1).
H202-scavenging activities of ampicillin and sulbactam.
Addition of ampicillin (50 to 300 ,g/ml) to H202 resulted in
a decrease in the H202 concentration (Table 2). Identical
results were obtained when DTPA or EDTA was added to
prevent metal-catalyzed H202 degradation. The absorbance
changes observed upon addition of ampicillin to the H202
solution were consistent with >500 H202 molecules being
decomposed for each added ampicillin molecule. Sulbactam
(256 ,ug/ml) did not induce decreases in the H202 concentra-
tion (Table 2). Catalase, an enzyme that degrades H202 to 02
and H20, induced the expected rapid decomposition ofH202
(Table 2).
To determine whether ampicillin possessed catalase-like
activity, we examined changes in 02 concentration during
ampicillin-induced degradation of H202 with an 02 elec-
trode. Under these conditions, catalase generated 02. No
oxygen evolution was observed from KRG in the absence of
H202 or from the addition of ampicillin to an H202 solution
(data not shown).
Hypochlorite scavenging by ampicillin and sulbactam. Neu-
trophil LEL results primarily from formation of OCI- (9) and
to a lesser extent from formation of 02- (8, 9) and HO (13)
(see reactions 1 through 3). OCI- can be measured by the
chlorination of MCD (11). Addition of ampicillin to MCD
prevented chlorination of MCD by OCI-, to an extent
dependent upon the ampicillin concentration (Fig. 3). Prein-
cubation of OCI- with sulbactam for 5 min before addition to
the MCD solution significantly inhibited MCD chlorination
(Fig. 3), but addition of sulbactam to MCD prior to OCI-
addition to the mixture failed to prevent chlorination of
MCD. Addition of NaOCl to luminol resulted in an immedi-
ate spike of luminescence which was greatly reduced by the
addition of ampicillin (Fig. 4). Sulbactam also inhibited
NaOCl-induced LEL, but to a lesser extent than did ampi-
cillin (Fig. 4).
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cence signal that was less intense than that produced by a
50-fold-lower concentration of OC- but that was somewhat
longer lived and was not attenuated by ampicillin (300 ,ug/ml)
(data not shown). The product of the reaction between
ampicillin and OCI-, however, did not induce luminescence
when added to luminol (data not shown), indicating that
ampicillin chloramine, if formed, does not contribute to
LEL.
Scavenging of HO' by ampicillin and sulbactam. The hy-
droxyl radical is the most potent ROI. Neutrophils can
generate HO' by myeloperoxidase-dependent (reaction 2)
(21) and transition metal-dependent (reaction 3) (3, 10)
reactions. HO can be measured most specifically by spin-
trapping techniques (3, 7, 21). Upon generation of HO via
the Fenton reaction in the presence of equimolar ampicillin
and DMPO, the intensity of the HO-DMPO adduct signal in
the EPR spectrum was decreased by 95% (P < 0.001)
compared with the result in the absence of ampicillin (Fig.
5). Similarly, sulbactam in a 1:1 molar ratio to DMPO
decreased the intensity of the DMPO-OH signal by 35% (P <
0.01). In other words, both ampicillin and sulbactam scav-
enge HO, with ampicillin being much more effective. How-
ever, the concentrations of ampicillin and sulbactam re-
quired for this type of specific spin-trapping assay are
considerably greater than those used elsewhere in this study
(Fig. 5).
Effects of ampicillin and sulbactam on myeloperoxidase
activity. Myeloperoxidase reacts with H202 and Cl- to
generate OCI- (reaction 1), and OCI- can react with 02 to
form HO (reaction 2). Myeloperoxidase activity was unaf-
fected by ampicillin or sulbactam (data not shown).
Effects of sulbactam on bacterial killing by PMN. The
effects of beta-lactam antibiotics on neutrophil killing have
been studied extensively (see Discussion) (25, 27). It has
previously been reported that sulbactam can also affect
neutrophil killing of bacteria (14, 20, 23). Direct treatment of
PMN with sulbactam (2, 5, or 10 ,ug/ml) had no effect upon
their ability to kill S. aureus (data not shown). Sulbactam
pretreatment of S. aureus 502A (192 ,ug/ml) or E. coli ATCC
25922 (64 p,g/ml) did not affect their growth (Fig. 6). Treat-
ment of these organisms with sulbactam at these sublethal
concentrations had minimal effects upon subsequent neutro-
phil killing (Fig. 6).
DISCUSSION
0 50 100 150 200 250 300 Ampicillin reduced LEL from PMN stimulated with op-
concentration (ug/ml) sonized zymosan by 40% and increased the latency periodbetween stimulation and luminescence. The degree of inhi-
2. Dependence of LEL of stimulated neutrophils on the bition we observed was consistent with that reported with
ation of added ampicillin (A) or sulbactam (B). The results similar experimental protocols (2).
t the means and standard errors of the mean from experi- siia.xprmna prtcl 2. . .;ingthe mepansrandesta arda rors of the. Sulbactam, either alone or in combination with ampicillin,,ing two separate preparations of PMN. also inhibited the chemiluminescent response of PMN stim-
ulated with opsonized zymosan. This result is in contrast
with earlier reports on the effects of sulbactam on chemilu-
nescence from chloramines. Primary amines such as minescence of PMN, in which case sulbactam alone slightly
(which is present in PMN at high concentrations) and increased the chemiluminescent response of PMN stimu-
Lin react with OCI- to form chloramines, which are lated with opsonized zymosan and abrogated the inhibitory
ly long-lived oxidants (26). Oxidation of luminol by effects of ampicillin (23). In the earlier studies sulbactam and
oramines potentially formed from taurine and/or ampicillin were used at much lower concentrations (0 to 20
Lin by stimulated PMN may therefore contribute to p,g/ml) and were incubated with neutrophils for 30 min prior
L observed in the presence of ampicillin or sulbac- to neutrophil stimulation.
order to test this hypothesis, the products of the Experiments were conducted to understand the mecha-
IS between taurine or ampicillin and OC1- were nisms and possible significance of ampicillin-induced inhibi-
linto solutions of luminol by the same protocol used tion of LEL. Hypochlorite, the primary oxidant generated

























TABLE 1. Effects of ampicillin and sulbactam on reduction of ferricytochrome c by superoxide generated by stimulated PMN or by
xanthine oxidase reacting with lumazinea
02- source Additions
Cyt c reduction rateb
XO PMN Ampicillin Sulbactam SOD (nmol/min)
(mU/ml) (105/ml) (4/ml) (ag/ml) (U/ml)
0 2 0 0 0 1.8 0.6
0 2 300 0 0 1.6 ± 0.6
0 2 0 256 0 2.4 ± 0.8
0 2 0 0 4.3 0.1 ± 0.1C
4 0 0 0 0 0.41 ± 0.05
4 0 300 0 0 0.47 ± 0.09
4 0 0 256 0 0.30 ± 0.03
4 0 0 0 4.3 0.05 ± 0.05d
a The source of superoxide was either PMN stimulated with 1 jg of PMA per ml or xanthine oxidase (XO) reacting with lumazine (see Materials and Methods).
Catalase was present in all reactions to prevent reoxidation of cytochrome c (Cyt c) by H202 formed by the disproportionation of the °2 produced in the reaction.
b Results represent the means and standard deviations of two or three independent experiments.
c Significantly different from the control (P < 0.1). Significance was determined by Student's t test.
d Significantly different from the control (P < 0.01). Significance was determined by Student's t test.
product in a chain of ROI generated starting with 02-
production and ending with the enzyme myeloperoxidase,
which converts H202 and Cl- to OCl- (12, 15). Inhibition of
any of the intervening steps in OC1- production and scav-
enging of other oxidants produced by PMN, including HO,
would also result in the attenuation of the luminescent
response of PMN. We looked for effects of ampicillin and
sulbactam in each step of the ROI cascade that could affect
LEL.
Neither ampicillin nor sulbactam prevented the produc-
tion of 02 by stimulated PMN, nor did they scavenge 02
in a cell-free system (Table 1) or interfere with myeloperox-
idase function. Ampicillin, but not sulbactam, scavenged
H202. Ampicillin degradation by H202 has been reported,
with the beta-lactam of the ampicillin being oxidatively
cleaved by H202, resulting in the formation of a quasistable
nitrone species (18). Ampicillin, and to a lesser extent
sulbactam, scavenged OCI- and also HO. These results
demonstrate that the H202-, HO-, and OCI--scavenging
activities of ampicillin are likely to be the source of its effects
upon PMN-induced luminescence. As sulbactam is a less
effective HO scavenger than is ampicillin, scavenging of
OCl- appears to be a more significant contributor to at-
tenuation of LEL by sulbactam. Briheim and Dahlgren
TABLE 2. H202 decomposition induced by ampicillin
and/or sulbactam
Ampicillin Sulbactam Catalase Rate of H202AmpicillinL/m) U decomposition'(jig/ml) (p.g/ml) (U) (jImol/min)
0 0 0 0.0
300 0 0 1.86 ± 0.02
200 0 0 1.29 ± 0.10
100 0 0 0.54 ± 0.01
50 0 0 0.23 ± 0.06
300 256 0 0.86 ± 0.01
0 256 0 0.09 ± 0.09
0 0 5 16.0
a Identical results were obtained with either EDTA (0.1 mM) or DTPA (0.1
mM) present. Results represent the means and standard deviations of three
separate experiments. Analysis of the results by Student's t test indicates that
all results with ampicillin present are significantly different from the control
results (P < 0.01), except for the case of 50 jig of ampicillin per ml (P < 0.1).
The rate of H202 decomposition in the presence of sulbactam but without
ampicillin is not significantly different from the control value.
suggested that ampicillin-induced inhibition of myeloperox-
idase-dependent LEL is due to interference with hypochlo-
rite or singlet oxygen (2).
The degree to which LEL from stimulated PMNs is
inhibited by ampicillin and sulbactam is likely to be limited
by several factors. Lack of access of antibiotics to all cellular
compartments in which ROI are generated may prevent
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FIG. 3. Demonstration of scavenging of hypochlorite by ampi-
cillin and sulbactam. Sodium hypochlorite (90 nmol) was added to
solutions containing MCD and ampicillin at various concentrations
(open circles) in the absence or presence of sulbactam at 256 ,ug/ml
(closed circle). Sulbactam (256 ,ug/ml) was incubated with OCl- for
5 min prior to the addition of the sulbactam-OCI- mixture to an
MCD solution (open triangle) or was added to the MCD solution
prior to exposure to OCl- (closed triangle). Scavenging of OCI- by
either antibiotic was observed as a reduction in the amount of MCD
chlorinated by added OCI- induced by the presence of the given
antibiotic. The results presented are the means and standard devi-
ations of four separate experiments.
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FIG. 4. Effects of ampicillin and sulbactam upon luminescence
induced by injection of NaOCl into a solution of luminol. Open
circles, ampicillin; closed circles, sulbactam. Results represent the
means and standard deviations of three separate determinations.
portion of the LEL response of activated PMN is due to
luminol oxidation by taurine chloramine, which is not signif-
icantly affected by ampicillin.
Antibiotics can effect bacterial killing in a variety of ways,
the most important of which may be sensitizing the organ-
isms to neutrophil attack (25, 27). Antibiotics can also affect























FIG. 5. EPR spectra of DMPO after exposure to Fe2" and H202
to allow hydroxyl radical formation. A, No antibiotic added; B,
ampicillin (5 mM) was in the reaction mixture; C, Sulbactam (5 mM)
was in the reaction mixture; D, catalase was added to the mixture
prior to the addition of H202 as a negative control. The signals in
spectra A, B, and C are typical of the hydroxyl radical adduct of
DMPO. The spectra were recorded with the following instrument
settings: gain, 5.0 x 103; modulation amplitude, 1.0 G; modulation
frequency, 100 kHz; microwave power, 20 mW; microwave fre-
quency, 9.32 GHz; time constant, 0.128 s. Spectra were recorded at
a rate of 25 G/min. Results are typical of three separate experiments
with various H202 concentrations.
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FIG. 6. Effects of sublethal sulbactam pretreatment on survival of
bacteria exposed to PMN in the presence of 10% normal human
serum. Bacteria (3.5 x 107 CFU) were pretreated with sulbactam for
30 min at 37°C in KRG and resuspended in 10% serum without
sulbactam prior to addition of PMN (5 x 106). (A) S. aureus 502A.
Triangles, no added PMN and no sulbactam treatment of bacteria;
squares, no treatment of bacteria with sulbactam; circles, sulbactam
(128 pLg/ml) pretreatment; diamonds, sulbactam (128 ,ug/ml), no PMN,
10% serum present. The results of three separate experiments were
analyzed by Student's t test, and no significant difference could be
detected between the control and sulbactam results, either in the
presence or in the absence of PMN. (B) E. coli ATCC 25922.
Triangles, no added PMN and no sulbactam pretreatment; squares,
no sulbactam pretreatment; circles, sulbactam (64 ,ug/ml) pretreat-
ment; diamonds, sulbactam (64 ,ug/ml) in 10% serum, no added PMN.
All results were typical of four separate determinations; no greater
effect was observed at lower concentrations of sulbactam. The results
of the four separate determinations were examined by Student's t test
for any significant effect of sulbactam, and the null hypothesis (i.e.,





















been reported that sulbactam enhances neutrophil bacterial
killing (14, 23). We observed no difference in killing of E. coli
or S. aureus by neutrophils in the presence of sulbactam (64
or 192 ptg/ml, respectively).
In summary, we have confirmed ampicillin-mediated inhi-
bition of neutrophil LEL (2) and have defined the mecha-
nisms for this phenomenon. The clinical significance of such
inhibition is unclear. Ampicillin scavenges H202 and OCI-.
Both ROI are important in microbicidal reactions in vitro (7)
and in vivo (16). On the other hand, ampicillin may not
achieve in vivo intracellular concentrations required to pro-
duce maximal inhibition of ROI. The successful use of
ampicillin for a wide variety of infectious diseases suggests
that direct interaction of this drug with phagocytes is out-
weighed by its effects on bacterial pathogens. Sulbactam is
an important adjunct to beta-lactam therapy. However, from
our results, we would expect sulbactam to have a negligible
effect on host defenses.
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